Technical Analysis for AKBA - Akebia Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 8.1 -0.86% -0.07
AKBA closed down 0.86 percent on Tuesday, March 19, 2019, on 2.02 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Flat Up Up
See historical AKBA trend table...

Date Alert Name Type % Chg
Mar 19 Fell Below 200 DMA Bearish 0.00%
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Earnings Movers Other 0.00%
Mar 19 Upper Bollinger Band Touch Strength 0.00%
Mar 18 200 DMA Support Bullish -0.86%
Mar 18 Calm After Storm Range Contraction -0.86%
Mar 18 Earnings Movers Other -0.86%
Mar 18 Upper Bollinger Band Touch Strength -0.86%
Mar 15 Crossed Above 200 DMA Bullish -0.86%

Older signals for AKBA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Biopharmaceutical Dialysis Chronic Kidney Disease Anemia Kidney Kidney Disease Hypoxia Inducible Factors
Is AKBA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.31
52 Week Low 5.2
Average Volume 1,089,446
200-Day Moving Average 8.1297
50-Day Moving Average 6.6574
20-Day Moving Average 7.4685
10-Day Moving Average 7.722
Average True Range 0.5108
ADX 42.44
+DI 38.0165
-DI 14.5629
Chandelier Exit (Long, 3 ATRs ) 7.767600000000001
Chandelier Exit (Short, 3 ATRs ) 7.9524
Upper Bollinger Band 8.4341
Lower Bollinger Band 6.5029
Percent B (%b) 0.83
BandWidth 25.857937
MACD Line 0.4137
MACD Signal Line 0.3584
MACD Histogram 0.0553
Fundamentals Value
Market Cap 148.23 Million
Num Shares 18.3 Million
EPS -3.60
Price-to-Earnings (P/E) Ratio -2.25
Price-to-Sales 6.10
Price-to-Book 12.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.32
Resistance 3 (R3) 9.31 8.90 9.11
Resistance 2 (R2) 8.90 8.59 8.90 9.04
Resistance 1 (R1) 8.50 8.40 8.70 8.51 8.98
Pivot Point 8.09 8.09 8.19 8.09 8.09
Support 1 (S1) 7.69 7.78 7.89 7.70 7.22
Support 2 (S2) 7.28 7.59 7.28 7.16
Support 3 (S3) 6.88 7.28 7.09
Support 4 (S4) 6.89